Delivery Order SPE2DB24D2205-SPE2DB24FDWTS

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of RABAVERT RABIES VACCINE with diluents to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $3,088.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has an ultimate completion date of April 26, 2024 and does not have a set-aside designation....
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, valued at $2,895.45. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a wide...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $3,860.60 firm fixed price delivery order has a completion date of November 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of medical commodities,...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the provision of RABAVERT rabies vaccine with diluents to the U.S. government. The $53,477.69 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government, including the Department of Defense (DoD) and Veterans Affairs (VA). This award is part of a larger Indefinite Delivery Contract...
The federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, valued at $15,718.50. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of May 27, 2025. No set-aside designation is mentioned, indicating this was an open competition....
This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS, valued at $50,393.66. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of May 9, 2023 and is a Firm Fixed Price delivery order. This contract award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The $48,309.89 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on June 25, 2024, with a completion date of June 26, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The firm fixed-price delivery order, valued at $12,017.42, has an ultimate completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award is for the delivery of RABAVERT Rabies Vaccine with diluents, valued at $1,219.60. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp as the prime contractor. The firm-fixed-price delivery order has a ceiling value of $3,860.60 and a completion date of November 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDWTS
    Delivery Order

This federal contract award is for the delivery of the RABAVERT rabies vaccine with diluents to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,421.72, was awarded to the Corporate Office Division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a firm-fixed price delivery order with a completion date of July 15, 2024. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support the DLA's mission of providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The current contract award for the RABAVERT vaccine does not have a set-aside designation.

Generated 10/11/24, 9:24 AM